MY105595A - Stable aqueous solutions of primycin pharmaceutical and cosmetic compositions containing these solutions and process for preparing same
- Google Patents
Stable aqueous solutions of primycin pharmaceutical and cosmetic compositions containing these solutions and process for preparing same
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es VegyeszetifiledCriticalChinoin Gyogyszer Es Vegyeszeti
Priority to MYPI90000425ApriorityCriticalpatent/MY105595A/en
Publication of MY105595ApublicationCriticalpatent/MY105595A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
THE INVENTION RELATES TO NOVEL STABLE AQUEOUS PRIMYCYN SOLUTIONS CONTAINING 0.5 TO 1.75% BY MASS/VOLUME OF PRIMYCIN SULFATE OR 2.5 TO 9% BY MASS/VOLUME OF A COMPLEX OF PRIMYCIN WITH N-METHYLPIRROLIDONE AND 2 TO 15% BY MASS/VOLUME OF PYROGLUTAMIC ACID, PREFERABLY L-PYROGLUTAMIC ACID OR A SOLUBLE SALT, PREFERABLY THE SODIUM SALT THEREOF AS CALCULATED FOR THE VOLUME OF THE SOLUTION TO BE PREPARED AND 40 TO 60% BY VOLUME OF ISOPROPANOL AS CALCULATED FOR THE VOLUME OF THE SOLUTION TO BE PREPARED AS WELL AS WATER IN AN AMOUNT SUPPLEMENTING UP TO 100 %.THE INVENTION FURTHER RELATES TO PHARMACEUTICAL OR DISINFECTING COSMETIC COMPOSITIONS MAINLY FOR TOPICAL TREATMENT CONTAINING THE ABOVE PRIMYCIN SOLUTION OPTIONALLY IN ADMIXTURE WITH PHARMACEUTICALLY ACCEPTABLE AUXILIARY MATERIALS AND, IF DESIRED, WITH OTHER NON-SYNERGISTIC THERAPEUTICALLY ACTIVE INGREDIENT(S), SUITABLY DESQUAMATING AND/OR ANTIINFLAMMATORY AGENT(S). THE INVENTION FURTHER RELATES TO THE PREPARATION OF THE ABOVE PRIMYCIN SOLUTIONS AND COMPOSITIONS CONTAINING THESE SOLUTIONS.
MYPI90000425A1990-03-191990-03-19Stable aqueous solutions of primycin pharmaceutical and cosmetic compositions containing these solutions and process for preparing same
MY105595A
(en)
Pharmaceutical preparation for producing a stabilized powder which contains a combination of acetylsalicylic acid and metoclopramide as the active ingredient
Process for producing new opioid receptorantagonist penta- and hexapeptide derivatives and pharmaceutical compositions comprising same as active ingredient